Prof. Dr. Tunç ÇATAL is a Professor of Molecular Biology and Genetics at Üsküdar Üniversitesi. He holds a PhD from İstanbul Technical University (2008) and conducted postdoctoral research at Oregon State University and the National University of Ireland Galway. His expertise spans microbial biotechnology, molecular biology, and hydrogen production. Education: BSc in Biology, İstanbul University (2001) MSc in Biology, İstanbul University (2004) PhD in Molecular Biology-Genetics and Biotechnology, İstanbul Technical University (2008) Administrative Roles: Head of Molecular Biology and Genetics Department (English Program) Director of PROMER Research Center Bologna Coordinator and Erasmus Coordinator His research focuses on microbial electrochemical systems, bioremediation, and bioenergy. Notable contributions include optimizing hydrogen production using microbial electrolysis cells and studying the effects of pharmaceuticals on microbial fuel cell efficiency. He has supervised 3 graduate theses and holds TÜBİTAK awards for impactful publications. His work integrates environmental science and molecular biology, with applications in sustainable energy (e.g., hydrogen production) and wastewater treatment. Recent studies explore novel curcumin compounds for toxicity mitigation and marine mucilage-based bioelectrochemical systems.
جستجوی استاد راهنمای دانشگاهی
برای مسیر پژوهشیتان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آنها ارتباط بگیرید.
نمایش ۱۶-۳۰ از ۳٬۳۶۴ استاد راهنما
اطلاعات پروفایلها از صفحات عمومی دانشگاهها گرفته شده و ممکن است بهروز نباشد.
- Survival analysis
- Clinical trials
- Cancer research
- +۴ مورد دیگر
Pingfu Fu, PhD, is a Professor in the Department of Population and Quantitative Health Sciences at Case Western Reserve University's School of Medicine. He is also a member of the Developmental Therapeutics Program at the Case Comprehensive Cancer Center. His expertise spans biostatistics, mathematics, and computer science, with a focus on cancer research and HIV/AIDS. Dr. Fu advises researchers on study design and statistical methodology for clinical and pre-clinical studies. He teaches courses in survival data analysis and clinical trials, and was recognized as 'Professor of the Year' in 2010 by the Department of Epidemiology and Biostatistics. Education: PhD in Biostatistics (Case Western Reserve University, 2001), MS in Statistics (Case Western Reserve University, 1996), MS in Mathematics (Xiangtan University, 1988), and BS in Mathematics (Jiangxi Normal University, 1984). His research interests include survival analysis, tree-based methods, clinical trials, and statistical applications in medical research. He has co-authored numerous peer-reviewed articles, focusing on cancer disparities, radiomics, and computational pathology. Professional memberships include the American Statistical Association, American Mathematical Society, and American Cancer Society. Dr. Fu holds editorial roles at Reviews on Recent Clinical Trials , Journal of Clinical Oncology , and Journal of the National Cancer Center . His work has addressed mathematical challenges in stochastic processes and resolved statistical issues in study design and tree-based models. Notable contributions include developing risk prediction models for cancer outcomes and advancing interdisciplinary collaborations across oncology, biostatistics, and computer science. His lab focuses on integrating computational methods with clinical data to improve patient outcomes.
Catherine Mooney is a Professor in the School of Computer Science at University College Dublin (UCD), leading the Life Science Data Analytics Group (LiSDA). Her research focuses on applying machine learning to healthcare challenges, including biomarker development, clinical decision support systems, and addressing ethical and technical barriers in healthcare AI. Education: BSc in [field unspecified] from Trinity College Dublin PhD in Computer Science from UCD Prof Dip University Teaching & Learning from UCD Research Interests: Machine Learning applications in healthcare Biomarker discovery for neurological and metabolic conditions Explainable AI for clinical decision support Promoting diversity and inclusion in STEM education Her work bridges computational methods with medical challenges, emphasizing ethical AI and translational research. Notable Awards: Best Paper Award in Applied Biosciences (2023) UCD Long-Service Award (2022) Best Poster Award at ITiCSE ’20 (2020) Her research has led to impactful tools like LiSDA’s clinical decision support systems for epilepsy and pregnancy care. She also advocates for gender diversity in computing, serving in leadership roles like Vice Principal for EDI in UCD’s College of Science (2022–2024).
João F. Mano is a Full Professor at the Department of Chemistry, University of Aveiro, and Director of the Doctoral Program on Biotechnology. He leads the COMPASS Research Group and serves as Vice-Director at CICECO - Aveiro Institute of Materials. His academic appointments include Invited Professor at University of Lorraine (France), Visiting Professor at KAIST (South Korea), and Adjunct Professor at Ajou University (South Korea). Education: PhD in Chemistry (1996, Technical University of Lisbon); D.Sc. in Tissue Engineering, Regenerative Medicine and Stem Cells (2012, University of Minho) Research Interests focus on Biomaterials for Regenerative Medicine , integrating Nanotechnology , Microtechnology , and Biofabrication . His group develops Bioinspired Materials using polymer chemistry, Decellularized Extracellular Matrix , and 3D Bioprinting to engineer Cell Microenvironments for therapeutic applications. Recent Publications highlight advancements in Human-Derived Hydrogels , Photopolymerizable Scaffolds , Magneto-Responsive Biomaterials , and Programmable Bioinks . Trends show emphasis on Organ-on-a-Chip integration, Smart Living Materials , and Green Bioprinting methodologies. Scientific Awards include: European Research Council Advanced Grants (2015, 2020) Fellow at IUPAC, European Academy of Sciences, and American Institute of Medical and Biological Engineering ERC Proof of Concept Grants Doctor Honoris Causa from University of Lorraine and Utrecht UNESCO Chair on Biomaterials George Winter Award (European Society for Biomaterials) Supervisions & Collaborations encompass 74+ MSc, 26+ PhD students, and 40+ postdocs. He co-founded METATISSUE and CELLULARIS Biomodels , and serves as Editor-in-Chief of Materials Today Bio .
- Nano-based drugs
- Precision medicine
- Immunology
- +۳ مورد دیگر
J. Christopher Love is the Raymond A. (1921) and Helen E. St. Laurent Professor of Chemical Engineering at MIT, with affiliations to the Koch Institute for Integrative Cancer Research, Broad Institute, and Ragon Institute. He earned a BS in Chemistry from the University of Virginia and a PhD in Physical Chemistry from Harvard University under George Whitesides, followed by postdoctoral work under Hidde Ploegh at Harvard Medical School. His research focuses on single-cell analysis, precision medicine, and biomanufacturing. The Love Lab develops technologies for drug discovery, vaccine development, and equitable biologic medicine production. Notable successes include pioneering single-cell analysis platforms, advancing metastatic cancer diagnostics via liquid biopsies, and engineering yeast-based vaccine manufacturing. Recent articles highlight innovations in liquid biopsy sensitivity, AI-driven ECG diagnostics, and CAR T-cell therapies. Awards include the Keck Young Scholar (2009), Dana Scholar (2009), and Camille Dreyfus Teacher-Scholar. He co-founded OneCyte, HoneyComb, and Sunflower Therapeutics, and advises multiple biotech companies. His lab emphasizes translational research, integrating chemical and biological engineering principles to address global healthcare challenges. Current work explores manufacturability-by-design for vaccines, tumor immunology, and mucosal vaccine delivery systems.
Tiffany Hoمشاهده پروفایل
استادیار
Dr. Tiffany Ho is an Assistant Professor in the Department of Psychology at the University of California, Los Angeles (UCLA). She is also affiliated with the Cognition, Affect, and Neurodevelopment in Youth (CANDY) lab, where she leads research on adolescent neurodevelopment, depression, and the neurobiological impacts of early adversity. Her work integrates neuroimaging, psychophysiology, and immunology to understand how stress and adversity shape brain circuits underlying emotion and behavior during adolescence. Education: Ph.D. in Psychology, University of California, San Diego B.A. in Cognitive Science, University of California, Berkeley Postdoctoral Fellowship in Clinical Neuroscience, University of California, San Francisco Postdoctoral Training in Affective Science, Stanford University Research Interests: Dr. Ho’s research focuses on understanding how brain circuits underlying thoughts, emotions, and behaviors change during adolescent development. She investigates how experiences of adversity and perceptions of stress shape neurodevelopment, and how these changes impact the etiology, course, and treatment of depression. Her lab uses a multimodal approach, including behavioral, cognitive, endocrine, immune, and neuroimaging techniques, and leverages big data and global initiatives to identify robust brain imaging markers associated with depression and related conditions. Grants and Funding: Her research has been generously funded by the Klingenstein Third Generation Foundation and the National Institute of Mental Health . Publications and Impact: Dr. Ho has published extensively in high-impact journals, with over 100 peer-reviewed articles. Her recent work includes studies on the effects of COVID-19 on adolescent mental health, the role of inflammation in depression, and the use of machine learning to classify major depressive disorder using neuroimaging data. She is also a key contributor to the ENIGMA consortium, a global initiative aimed at understanding brain alterations in psychiatric disorders.
- RNA Metabolism
- Non-coding RNAs
- Cancer Metastasis
- +۳ مورد دیگر
Claudio R. Alarcón is an Associate Professor in Pharmacology at Yale University School of Medicine. His research focuses on RNA metabolism's role in development, health, and disease, particularly RNA modifications and non-coding RNAs. He joined Yale in 2017 after postdoctoral training at The Rockefeller University and holds a PhD from Cornell University (2009) and a BSc from Pontificia Universidad Católica de Chile (1999). Research Interests: Functional roles of m6A RNA modifications MicroRNA biogenesis and cancer progression Non-coding RNA regulation in metastasis Key Appointments: Primary Faculty, Yale Cancer Biology Institute Member, Yale Cancer Center Faculty, Yale Combined Program in Biological and Biomedical Sciences His lab integrates bioinformatics, molecular, and cellular approaches to study cancer metastasis mechanisms, including miRNA processing disruptions and SOX4/TMEM2 pathways linked to clinical outcomes.
Jennifer Broderick is a Lecturer at the RNA Therapeutics Institute within UMass Chan Medical School in Worcester, MA. Her academic journey includes a BA from the University of Wisconsin School of Medicine and Public Health, a BS in Molecular Biology from the University of Wisconsin-Madison, and a PhD in Philosophy from the University of Massachusetts Medical School. Her research focuses on RNA therapeutics, microRNA function, and molecular biology mechanisms. Key areas include: RNA interference and silencing pathways MicroRNA quantification and therapeutic applications Gene regulation through splicing mechanisms Protein-RNA interactions in mammalian systems Her publications show consistent focus on RNA biology, with recent work advancing therapeutic RNA design and microRNA quantification techniques. Earlier research explored tau protein splicing and RNA silencing mechanisms. Dr. Broderick collaborates with prominent researchers including Phillip Zamore and Guangping Gao, and is part of the RNA Therapeutics Institute research community.
Michael Boutros is a Full Professor at Heidelberg University and Head of Division at the German Cancer Research Center (DKFZ). He currently serves as Dean of the Medical Faculty at Heidelberg University (since 2023) and Director of the Marsilius Kolleg (since 2020). He has held leadership roles including Coordinator of the Functional and Structural Genomics Program at DKFZ (2014–2023) and Acting Scientific Director (2015–2016). His academic base is within the Medical Faculty, focusing on molecular oncology and functional genomics. PhD, Witten/Herdecke University (1993–1996) Postdoctoral Research, Harvard Medical School (1999–2003) MPA, John F. Kennedy School of Government, Harvard University (1999–2001) Additional training: Cold Spring Harbor Laboratory, SUNY Stony Brook His research centers on Wnt signaling, functional genomics, and cancer pathways. He leads major research initiatives such as CRC 1324 on Wnt signaling and the ERC Synergy Grant DECODE. His work integrates high-throughput screening, CRISPR, and systems biology to dissect signaling networks in cancer and development. He has pioneered genome-wide RNAi and CRISPR screens to identify novel regulators of Wnt signaling across models. The 15 most recent articles reflect a strong focus on Wnt pathway regulation using functional genomics in both Drosophila and mammalian systems. Themes include high-throughput screening, CRISPR-based validation, cross-species conservation, and therapeutic targeting. Keywords span Cancer Biology, Systems Biology, and Signal Transduction, with subfields like RNAi, ubiquitination, stem cell regulation, and machine learning in image analysis. Michael Boutros has received numerous scientific honors: Elected member, Leopoldina National Academy of Sciences (2022) Elected member, Heidelberg Academy of Sciences (2022) EMBO Member (2013) ERC Advanced Grant (2012) Johann-Georg Zimmermann Research Award (2007) EMBO Young Investigator (2005) Member, 'Die Junge Akademie' (2003) He has been a recipient of the Emmy-Noether Program, McCloy Fellowship, Boehringer Ingelheim PhD Fellowship, Studienstiftung Fellowship, and Fulbright Fellowship. As a mentor and research leader, he has supervised numerous early-career scientists and coordinated large collaborative grants including the FP7 'CancerPathways' project. He currently serves as Speaker of the Research and Strategy Commission at Heidelberg University and Managing Director of the Health and Life Science Alliance Heidelberg Mannheim. He leads the CRC 1324 on Wnt signaling and is Coordinating PI of the ERC Synergy Grant DECODE. He is also Spokesperson of DFG Research Group 1036 and Coordinator of the former FP7 Coordinated Project 'CancerPathways'. His lab employs cutting-edge functional genomics tools to decode signaling networks in cancer and development.
Miler T. Leeمشاهده پروفایل
دانشیار
Miler T. Lee is an Associate Professor at the University of Pittsburgh , focusing on gene regulation during early embryonic development through high-throughput experimental and computational genomics. He earned his Ph.D. in Genomics and Computational Biology in 2009 from the University of Pennsylvania under Dr. Junhyong Kim, followed by postdoctoral work with Dr. Antonio Giraldez at Yale University. Joining the university in 2016, his research spans maternal-to-zygotic transition (MZT), RNA stability, pluripotency networks, and evolutionary developmental biology, utilizing model organisms like zebrafish, Xenopus, and Hydractinia symbiolongicarpus. Key Research Themes: Maternally inherited RNA dynamics during embryogenesis Mechanisms of RNA degradation and transcriptome remodeling Evolution of pluripotency networks in hybrid species Role of zinc signaling in fertilization barriers Computational tools for RNA regulation and sensing Scientific Awards: Pan-American Society for Evolutionary Developmental Biology Junior Faculty Award (2024) Outstanding New Investigator – International Xenopus Board (2023) Basil O'Connor Scholar – March of Dimes (2017-2019) Recent publications highlight his work on enhancer classification, RNA degradation mechanisms, and cross-species MZT comparisons. His lab develops innovative methods like RESA for regulatory sequence analysis and studies evolutionary divergence in RNA localization patterns. While the articles span computational and experimental approaches, they consistently address RNA's role in cellular identity, developmental timing, and evolutionary adaptation. Applications include understanding pluripotency, designing RNA biosensors, and elucidating fertilization barriers. Prospective Ph.D. students are encouraged to contact him for opportunities in gene regulation, development, evo-devo, and computational genomics.
Alexander Nikitin is a Professor of Pathology at Cornell University's College of Veterinary Medicine, Department of Biomedical Sciences. His research focuses on molecular mechanisms linking tissue homeostasis to cancer development using autochthonous mouse models. Key Affiliation: Cornell University, Ithaca, NY Research Niche: Cancer-prone stem cell niches in female reproductive tract and prostate Research Interests Dr. Nikitin investigates how aberrations in p53/miR-34/MET and Rb networks drive malignant transformation of adult stem cells. His work includes: Identification of ovarian surface epithelium stem cell niche Technology-oriented cross-disciplinary collaborations Characterization of cancer initiation mechanisms in reproductive tissues Article Trends His publications span 2003–2025, emphasizing: Mouse models for epithelial cancers Role of tumor suppressor genes (p53, Rb) in cancer miR-34 family's tumor suppression functions Stem cell niche mapping in reproductive tract cancers Genetic drivers of high-grade serous carcinomas Translational research applications Lab Members Current lab personnel include: Andrea Flesken-Nikitin (Assistant Research Professor) Christopher Ashe (Research Support Specialist) Technicians and student researchers
- Respiratory Science
- Asthma
- COPD
- +۵ مورد دیگر
Professor Sir Peter Barnes is a leading figure in respiratory science at Imperial College London's National Heart and Lung Institute (NHLI) . As Professor of Thoracic Medicine , his work focuses on Asthma, COPD, and cellular senescence in lung disease , with over four decades of contributions to understanding inflammatory pathways and therapeutic innovations. Research Interests Mechanisms of chronic airway inflammation in Asthma and COPD Cellular senescence in lung aging and disease progression MicroRNA transfer via extracellular vesicles in COPD pathogenesis Targeted drug delivery for respiratory conditions Global health implications of lung disease Recent Publications highlight trends in: MicroRNA regulation of senescence and inflammation Extracellular vesicle dynamics in lung disease Biologics and corticosteroid efficacy in respiratory conditions Environmental factors influencing COPD and asthma Scientific Recognition Knighthood (2023) for services to respiratory science Fellow of the Royal Society (FRS) and Academy of Medical Sciences (FMedSci) Collaborative Leadership at NHLI has mentored numerous postdocs and researchers. His work intersects with global initiatives like GOLD (Global Initiative for COPD) , influencing clinical guidelines and public health policy.
- Reproductive Medicine
- Obstetrics
- Gynaecology
- +۳ مورد دیگر
Professor Kristina Gemzell Danielsson is a Senior Physician and Head of the Department of Women's and Children's Health at Karolinska Institutet. She holds a Docent title (2000) and has been employed at Karolinska since 2006. Her research focuses on reproductive health, obstetrics, and gynaecology, with a particular emphasis on medical abortion protocols, contraception efficacy, and global health equity. She leads initiatives to improve access to safe abortion services and has contributed to policy reforms in reproductive health care. Her academic roles include: Head of Division for Neonatology, Obstetrics, Gynaecology, and Reproductive Health Member of international advisory boards on reproductive medicine Research interests span reproductive medicine, hormonal contraception safety, and the intersection of gender-based violence with healthcare. Key contributions include studies on telemedicine abortion, epigenetic biomarkers in cancer risk, and endometriosis pathophysiology. Her publications analyze over 50 studies, emphasizing translational research and global health impact. Notable work includes randomized controlled trials on medical abortion protocols and systematic reviews on climate change and sexual health.
Noelia Fernández Castillo is a Lecturer at the University of Barcelona's Faculty of Biology, affiliated with the Department of Genetics, Microbiology, and Statistics. She leads the Human Molecular Genetics research group and holds roles in academia spanning education and research. Education: Bachelor's/Master's in Genetics (University of Barcelona, 2004) Experimental Biology Master's (2006) Teaching Certification (2005) PhD in Biology (2011) Research focuses on genetic mechanisms underlying psychiatric disorders, addiction, and neurodevelopmental conditions. Key areas include epigenetic influences on ADHD, genetic contributions to aggression, and molecular pathways in substance use disorders. Uses animal models (zebrafish, mice) and human genomic data to explore these topics. Notable projects include studying nutrition's impact on impulsive behaviors (Eat2beNICE project, 2017-2022) and investigating shared genetic susceptibility between addictions and aggression. Current work emphasizes genetic pleiotropy in ADHD and psychiatric comorbidity. Has led/co-led grants from the European Union, Spanish Ministry of Health, and Ministry of Science. Active in collaborative research with institutions across Europe and North America.
Anne G Hoenمشاهده پروفایل
دانشیار
Anne G Hoen is an Associate Professor at the Geisel School of Medicine , Dartmouth College, with joint appointments in Epidemiology , Biomedical Data Science , and Microbiology and Immunology . Her research focuses on microbiome development in infants, environmental exposures, and their associations with health outcomes, using interdisciplinary approaches including statistical modeling and bioinformatics. Research Interests: She explores how microbial communities in early life influence disease risk through environmental and dietary factors. Her work integrates microbiome-metabolome interactions, computational methods for microbial network analysis, and epidemiological studies of infectious diseases. Recent Article Trends: 2025-2024 publications highlight maternal diet-microbiome links, microbial interaction networks, ECHO consortium collaborations, and novel computational approaches for microbiome data. Key sub-fields include perinatal exposome, microRNA profiling, and longitudinal metabolomic analysis. Scientific Awards: K01LM011985: Bioinformatics strategies for early life microbiomics R01LM012723: Multi-omic functional integration using networks Advising: Mentors current PhD students in Dartmouth's Quantitative Biomedical Sciences (QBS) program, including Becky Lebeaux and Quang Nguyen, while alumni like Sara Lundgren and Wes Viles hold postdoctoral and academic positions.